Shared Decision Making and Patient Engagement Program During AECOPD Hospitalization
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 主要终点
- Health related quality of life
研究概览
简要总结
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Patients require good communication with the physician to improve control illness. Shared decision making is a promising opportunity for chronic disease management due to the relative cost, medicine optimization and decreases hospital admissions/re-admissions
详细描述
Chronic obstructive pulmonary disease (COPD) is the leading one on hospital care cost, physician services, and prescription drugs. Additionally to the disease progression with the reduction in lung function, COPD patients experiment a progressive decline in functional capacity and health-related quality of life (HRQoL) with a significant burden in terms of disability. Shared Decision Making is defined as an approach where clinicians and patients share the available information to making clinical decisions, and where patients are counseled. SDM is a way to empower patients when decisions are made about treatment as a determinant factor in patient-centered care. Decision aids have been proven effective in improving disease knowledge, decision making, and self-care.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inclusion criteria were COPD patients hospitalized due to acute exacerbation
排除标准
- •Exclusion criteria were the inability to provide informed consent, the presence of psychiatric or cognitive disorders, progressive neurological disorders, organ failure, cancer, or inability to cooperate. Patients who had experienced another exacerbation of COPD in the previous month were also excluded.
结局指标
主要结局
Health related quality of life
时间窗: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
European Quality of Life questionnaire consists of the EQ-5D visual analog scale and the EQ-5D index. The visual analog scale has a rating scale of 0-100 (0 worst possible health, and 100 best possible health). The questionnaire has 5 domains: mobility, self-care, usual activity, pain, and anxiety-depression. For each item, the subject selects one of 3 descriptive health states (from good to poor).
次要结局
- Physical activity(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Nutritional status(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Functional capacity associated with breathlessness(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- COPD Knowledge(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Adherence of inhalers(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Functional capacity(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
研究者
Marie Carmen Valenza
Principal Investigator
Universidad de Granada